Company Information

Management Team

Front Page / Company Information / Management Team

Te-Li Chen (Te-Li), MD, PhD, Prof.

Board Chairman and General Manager

Twenty years of experience in clinical trials and clinical and basic research, ten years of experience in drug development and sales, and expertise in integrating multifaceted subject matter and clinical trial designs.

  • Education
  • College of Medicine, National Defense Medical Center
    PhD, Institute of Tropical Medicine, National Yang-Ming University
  • Current
  • Professor, Graduate Institute of Life Sciences, National Defense Medical Center
    Adjunct Professor, Graduate Institute of Clinical Medicine, National Yang-Ming University
    Adjunct Attending Physician, Division of Infectious Diseases, Taipei Veterans General Hospital
  • Experience
  • Chairman of the Board, Mycenax Biotech, Inc.
    Vice General Manager, BioEngine Technology Development, Inc.
    Vice General Manager, TTY Biopharm
    Associate Professor, National Yang-Ming University
    Attending Physician, Division of Infectious Diseases, Taipei Veterans General Hospital

Steve T Lin, D.Sc.

CEO

Dr. Lin is a highly skilled and respected biomedical engineer with global experience leading R&D, Technology, and Business Strategy teams to singular success. He has demonstrated an impressive history of stellar accomplishments from start-up ventures to the Fortune 500 company. During his 35 years career in biomedical device industry, Dr. Lin has a proven track record of technology innovations that have contributed significantly to the company's bottom line. In addition, he has built strong working relationships within national as well as international biomedical research communities. He is articulate, team-oriented, creative and strategic.

  • Education
  • D.Sc. Biomedical Engineering, Washington University, St. Louis, MO
    M.S. Biomedical Engineering, Drexel University, Philadelphia, PA
    M.S. Chemical Engineering, S.D. School of Mines & Tech., Rapid City, SD
    B.S. Chemical Engineering, University of Chinese Culture, Taiwan
  • Current
  • N/A
  • Experience
  • CEO, Exactech Taiwan
    Exactech, Inc. Vice President of Biologics and Chief Technology Officer
    Zimmer, Vice President of Global Research and Technology
    OrthoMatrix, Inc. Manager of Advanced Technology
    Hexcel Corporation, Research Specialist

Chia-Ling Hsiao (Carine), PhD.

Vice General Manager

Eighteen years of experience in drug review and regulatory affairs. Expertise in regulatory requirements pertaining to pharmaceutical registration and approval procedures for new drugs and generic drugs along with related regulatory frameworks for clinical trials. Specializes in regulatory frameworks and project management.

  • Education
  • PhD, College of Pharmacy, Taipei Medical University
    MS, School of Pharmacy, National Cheng Kung University
    BS, School of Pharmacy, China Medical University
  • Current
  • N/A
  • Experience
  • Director, Division of R&D III, Center Laboratory Inc.
    Director, Division of Pharmaceutical Science, Center for Drug Evaluation
    Team leader and Deputy Director, Division of Preclinical Science, Center for Drug Evaluation
    Pharmacokinetics Reviewer, Center for Drug Evaluation

4F, No. 3, Park Street, Nangang District, Taipei 115

info@biogend.com.tw

+886-2-2655-8366 Customer Service Telephone Number:0911-886-733

© 2019 BioGend Therapeutics Co.,Ltd. All rights reserved. 網頁設計 - 好點子數位創意